GOSS Gossamer Bio, Inc.

$10.73▼ -5.81% Healthcare Other
After hours $10.70▼ -0.28% Sep 11, 7:52 PM ET
Volume 472.1K Avg Volume (10D) 158.2K
Key Metrics & Fundamentals
Market Cap
$65.57M
P/E Ratio
–
Div Yield
–%
52W Range
9.12 - 309.60
% vs 50 MA
-20.16%
% vs 200 MA
-87.20%
RSI-14
36.9
MACD Histogram
-0.2600
Beta (1Y vs SPY)
2.24
Free Cash Flow
-$39.42M
Gross Rev
$9.24M
Gross Profit
$9.24M
EBITDA
-$29.70M
COGS
–
Operating Exp
$35.31M
Operating Income
-$26.07M
EBIT
-$26.07M
Pretax Income
$16.90M
Net Income
$16.90M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split
Business Wire · Sep 11, 2026 12:00 PM
Gossamer Bio Announces 1-for-80 Reverse Stock Split
Business Wire · Sep 9, 2026 1:00 PM
Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
GlobeNewswire · Sep 8, 2026 8:31 AM
Gossamer Bio to Present at Cantor Global Healthcare Conference
Business Wire · Sep 4, 2026 12:00 PM
Gossamer (GOSS) Announced Up to $250M of Financing, but Only $25M is Expected Upfront. Is the Runway Secure?
Insider Monkey · Aug 27, 2026 7:59 PM
Gossamer Bio announces $250m in funding to advance seralutinib
Pharmaceutical Technology · Aug 24, 2026 10:15 AM
Sector Update: Healthcare Stocks Advance in Afternoon Trading
MT Newswires · Aug 21, 2026 5:43 PM
BC-Most Active Stocks
Associated Press · Aug 21, 2026 2:30 PM
Gossamer Bio Secures Up to $250 Million Private Placement to Fund Seralutinib Through Potential FDA Approval
InvestorsHub · Aug 21, 2026 1:49 PM
Gossamer Bio Agrees to Up to $250 Million Private Placement; Shares Rise Pre-Bell
MT Newswires · Aug 21, 2026 12:34 PM
Financial Overview - Income Statement Quarterly

See GOSS's money flow as a full page

Social Sentiment
Avg +0.65 · 4 posts
NewsDiscussionIF YOU LOVE DRUGS , HERE'S A GOOD PILL TO TAKE (AUGUST) TICKER GOSS
r/stocks · Jul 31, 2026
Discusses a company in late-stage development with potential upside due to a recent rights acquisition.
positive +0.60
Trade2025 Gains Up 100%+
r/wallstreetbets · Jan 5, 2026
GOSS is listed as part of the author’s investment portfolio.
positive +0.30
DDNewsTradeUNUSUAL OPTION $GOSS
r/options · Dec 15, 2025
The post analyzes unusual option flow and Phase 3 trial data, expressing optimism about a potential catalyst.
positive +0.80
NewsTradePriceTargetDiscussionMemeGossamer Bio to the moon.. 🚀🌙
r/wallstreetbets · Oct 25, 2025
The author expresses extreme bullish sentiment ('to the moon') and references a significant price increase and future potential.
very_positive +0.90
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙